Search
Search Results
Found 7 items.
-
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis
Published: July 7, 201510577PDF: 4485SUPPLEMENTARY MATERIAL: 1008 -
Prostate-specific antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival
Published: February 22, 20231008PDF: 598 -
Novel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comparing outcomes. A single-center retrospective study
Published: December 20, 20211540PDF: 621 -
-
Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC
Published: October 1, 2020927PDF: 588
1 - 7 of 7 items